PCI Biotech Holding ASA
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of PCI Biotech Holding ASA generated cash of -$14,970,000, which is more than the previous year. Cash used in financing activities reached the amount of -$442,000 last year. Net change in cash is therefore -$15,412,000.
Cash Flow
| 2014 | -31.67M | 812K | 0 |
|---|---|---|---|
| 2015 | -32.84M | 867K | 65.46M |
| 2016 | -35.69M | 447K | 0 |
| 2017 | -30.62M | 677K | 66.73M |
| 2018 | -31.07M | 782K | 328.83M |
| 2019 | -83.47M | -3.62M | 526K |
| 2020 | -77.39M | -3.91M | -352K |
| 2021 | -68.30M | -341K | -673K |
| 2022 | -59.04M | 0 | -678K |
| 2023 | -14.97M | 0 | -442K |
PCIB.OL Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 56.59M | 116.11M | 187.96M | 261.10M | 349.32M | 50.78M | 14.00M | 49.24M | 15.75M | 46.59M |
Operating activities | ||||||||||
Net income | -20.31M | -55.09M | -88.39M | -72.23M | -88.74M | -34.78M | -42.84M | -32.18M | -31.92M | -35.84M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 371K | 6.40M | 2.54M | 2.20M | 955K | 5K | 6K | 5K | 4K | 4K |
Stock-based compensation expense | 1.95M | -1.29M | 12.93M | 6.33M | 2.43M | 0 | 4.86M | 986K | 1.62M | 1.55M |
| Deferred income tax benefit | 1.95M | -1.29M | 12.93M | 6.33M | 2.43M | 0 | 4.86M | 986K | 1.62M | 1.55M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 3.59M | 6.03M | 962K | 1.48M | -6.93M | -87K | 766K | -1.25M | -2.52M | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 217K | -3.25M | -1.44M | -3.41M | 6.71M | 392K | -584K | -1.29M | 785K | 0 |
Cash generated by operating activities | -14.97M | -59.04M | -68.30M | -77.39M | -83.47M | -31.07M | -30.62M | -35.69M | -32.84M | -31.67M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 | -341K | -3.91M | -5.40M | 0 | 0 | 0 | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 0 | 0 | -341K | -3.91M | -3.62M | 782K | 677K | 447K | 867K | 812K |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 0 | 316K | 1.18M | 361.22M | 71.72M | 0 | 65.46M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -678K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | -442K | -678K | -673K | -352K | 526K | 328.83M | 66.73M | 0 | 65.46M | 0 |
Net Change In Cash | -15.41M | -59.52M | -71.84M | -73.13M | -88.22M | 298.53M | 36.78M | -35.24M | 33.49M | -30.84M |
Cash at end of period | 41.18M | 56.59M | 116.11M | 187.96M | 261.10M | 349.32M | 50.78M | 14.00M | 49.24M | 15.75M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |